Treatment with gap junction inhibitor 18αGA partially abrogated the vinblastine-induced cytotoxicity in Caki-1 RCC cells, suggesting Cx32 mediated bystander effects through GJIC [93]. The gene discussed is GJB1; the disease is renal cell carcinoma.